Koers Advanced Proteome Therapeutics Corp. Other OTC
Aandelen
CA0076281009
Holdingvennootschappen
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 4,65 mln. 4,29 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -1 mln. -922K | Nettowinst (verlies) 2022 | - 0 | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 324K 298K | Nettoliquiditeiten 2022 | 31,61K 29,15K | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-4,85
x | K/w-verhouding 2022 |
6,03
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 89,84% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 16-04-18 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 10-03-09 |
Martin Woodward
BRD | Director/Board Member | 56 | 20-12-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 20-12-18 |
Cory Brandolini
BRD | Director/Board Member | 64 | 21-11-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+180,51% | 8,67 mld. | |
+2,29% | 983 mln. | |
+41,91% | 883 mln. | |
+26,17% | 825 mln. | |
+1,92% | 665 mln. | |
+9,52% | 664 mln. | |
-.--% | 600 mln. | |
+9,17% | 530 mln. | |
-.--% | 500 mln. |